Back

Yersinia pseudotuberculosis employs a multifaceted strategy to survive antimicrobials

Goode, O.; Woodward, J.; Lapinska, U.; Onime, J.; Farbos, A.; O Neill, P.; Jeffries, A.; Jenkins, C. H.; Norville, I. H.; Pagliara, S.

2026-03-04 microbiology
10.64898/2026.03.04.709318 bioRxiv
Show abstract

Microbes have evolved a variety of strategies to survive exposure to naturally occurring and synthetic antimicrobials. These strategies have been investigated extensively in model bacterial organisms, whereas less is known about under explored pathogenic bacteria such as bacteria within the Yersinia genus. In this study we investigated the inhibitory effect and bactericidal activity of antibiotics from five different classes and of the disinfectant hydrogen peroxide against Yersinia pseudotuberculosis, the ancestral species from which Yersinia pestis and Yersinia enterocolitica have emerged. We found that Y. pseudotuberculosis is able to survive exposure to clinical antibiotics and disinfectants by employing a variety of strategies, with persisters and the Eagle effect playing a role in survival to quinolones, tolerance playing a role in survival to ceftriaxone and overexpression of catalases and peroxidases playing a role in survival to hydrogen peroxide. Our findings suggest that future research should focus on informing new, effective ways to treat infections caused by Yersinia species. IMPORTANCEAntimicrobial resistance is routinely investigated by measuring the minimum inhibitory concentration of antimicrobials needed to stop microbial growth. Here we show that the bacterial pathogen Yersinia pseudotuberculosis is not killed when antibiotics and disinfectants are used at these concentrations and that, in some cases, increasing antibiotic concentrations decreases their activity against this bacterium, therefore posing a potential risk to human and animal health.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
mBio
750 papers in training set
Top 0.3%
22.7%
2
Microbiology
57 papers in training set
Top 0.1%
6.4%
3
Applied and Environmental Microbiology
301 papers in training set
Top 0.3%
6.4%
4
mSystems
361 papers in training set
Top 1%
6.4%
5
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 0.6%
4.9%
6
PLOS Pathogens
721 papers in training set
Top 3%
4.9%
50% of probability mass above
7
Environmental Microbiology
119 papers in training set
Top 0.6%
4.3%
8
mSphere
281 papers in training set
Top 1%
3.6%
9
Frontiers in Microbiology
375 papers in training set
Top 3%
3.1%
10
Microbiology Spectrum
435 papers in training set
Top 1%
2.8%
11
Pathogens
53 papers in training set
Top 0.3%
2.1%
12
ACS Infectious Diseases
74 papers in training set
Top 0.5%
1.9%
13
PLOS Neglected Tropical Diseases
378 papers in training set
Top 3%
1.9%
14
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 1%
1.7%
15
eLife
5422 papers in training set
Top 42%
1.7%
16
PLOS Biology
408 papers in training set
Top 11%
1.5%
17
PLOS ONE
4510 papers in training set
Top 58%
1.3%
18
Scientific Reports
3102 papers in training set
Top 64%
1.3%
19
Antibiotics
32 papers in training set
Top 1.0%
1.1%
20
Infection and Immunity
103 papers in training set
Top 0.6%
1.0%
21
Nature Communications
4913 papers in training set
Top 59%
0.9%
22
Virulence
21 papers in training set
Top 0.5%
0.8%
23
Molecular Microbiology
66 papers in training set
Top 0.9%
0.8%
24
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.8%
25
Cell Host & Microbe
113 papers in training set
Top 5%
0.7%
26
BMC Biology
248 papers in training set
Top 5%
0.7%
27
Microbiological Research
19 papers in training set
Top 0.9%
0.6%
28
Microbiome
139 papers in training set
Top 3%
0.6%
29
Microorganisms
101 papers in training set
Top 3%
0.6%
30
PLOS Genetics
756 papers in training set
Top 17%
0.6%